Evidence-Based Reviews

Bodybuilding’s dark side: Clues to anabolic steroid use

Current Psychiatry. 2004 December;3(12):12-20

References

1. Pope HG, Jr, Kanayama G, Ionescu-Pioggia M, Hudson JI. Anabolic steroid users’ attitudes towards physicians. Addiction 2004;99:1189-94.

2. Dawson RT. Drugs in sport—the role of the physician. J Endocrinol 2001;170:55-61.

3. Kutscher EC, Lund BC, Perry PJ. Anabolic steroids: a review for the clinician. Sports Med 2002;32:285-96.

4. Pope HG, Jr, Phillips KA, Olivardia R. The Adonis complex: the secret crisis of male body obsession. New York: Free Press, 2000.

5. Kouri EM, Pope HG, Jr, Katz DL, Oliva PS. Fat-free mass index in users and non-users of anabolic-androgenic steroids. Clin J Sport Med 1995;5:223-8.

6. Brower KJ. Anabolic steroid abuse and dependence. Curr Psychiatry Rep 2002;4:377-83.

7. Pope HG, Jr, Katz DL. Psychiatric effects of exogenous anabolic-androgenic steroids. In: Wolkowitz OM, Rothschild AJ (eds). Psychoneuroendocrinology: the scientific basis of clinical practice. Washington. DC: American Psychiatric Publishing, 2003;331-58.

8. Pope HG, Jr, Brower KJ. Anabolic-androgenic steroids. In: Galanter M, Kleber HD (eds). American Psychiatric Publishing textbook of substance abuse treatment (3rd ed). Washington DC: American Psychiatric Publishing, 2004;257-64.

9. Malone DA, Jr, Dimeff R, Lombardo JA, Sample BRH. Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users. Clin J Sports Med 1995;5:25-31

10. Kashkin KB, Kleber HD. Hooked on hormones? An anabolic steroid addiction hypothesis. JAMA 1989;262:3166-70.

11. Brower KJ, Eliopulos GA, Blow FC, et al. Evidence for physical and psychological dependence on anabolic androgenic steroids in eight weight lifters. Am J Psychiatry. 1990;147(4):510-2.

12. Malone DA, Jr, Dimeff RJ. The use of fluoxetine in depression associated with anabolic steroid withdrawal: a case series. J Clin Psychiatry. 1992;53:130-2.

13. Pope HG, Jr, Gruber AJ, Choi PY. Muscle dysmorphia: an underrecognized form of body dysmorphic disorder. Psychosomatics 1997;38:548-57.

14. Olivardia R, Pope HG, Jr, Hudson JI. ‘Muscle dysmorphia’ in male weightlifters: a case-control study. Am J Psychiatry 2000;157:1291-6.

15. Kanayama G, Pope HG, Jr, Cohane G, Hudson JI. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. Drug Alcohol Depend 2003;71:77-86.

16. Phillips KA. Pharmacologic treatment of body dysmorphic disorder: a review of empirical data and a proposed treatment algorithm. Psychiatr Clin North Am 2000;7:59-82.

17. Wines JD, Jr, Gruber AJ, Pope HG, Jr, Lukas SE. Nalbuphine hydrochloride dependence in anabolic steroid users. Am J Addictions 1999;8:161-4.

18. McBride AJ, Williamson K, Petersen T. Three cases of nalbuphine hydrochloride dependence associated with anabolic steroid abuse. Br J Sports Med 1996;30:69-70.

19. Kanayama G, Cohane G, Weiss RD, Pope HG, Jr. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? J Clin Psychiatry. 2003;64:156-60.

20. Arvary D, Pope HG, Jr. Anabolic steroids: a possible gateway to opioid dependence. N Engl J Med 2000;342:1532.-